Effects of preoperative chemoradiotherapy on postsurgical morbidity and mortality in cT3-4 +/- cM1lymph cancer of the oesophagus and gastro-oesophageal junction

European Journal of Cardio-thoracic Surgery

Volumn 24, Issue 2, 2003, Pages 179-186

  Hagry, O ^a   Coosemans, W ^a   De Leyn, P ^a   Nafteux, P ^a   Van Raemdonck, D ^a   Van Cutsem, E ^a   Hausterman, K ^a   Lerut, T ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Carcinoma of the esophagus gastroesophageal junction; Induction chemoradiotherapy; Lymphadenectomy; Postoperative morbidity; Postoperative mortality

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ACUTE PANCREATITIS; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ADVANCED CANCER; AGED; ANASTOMOSIS; ATELECTASIS; BLEEDING; BYPASS SURGERY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CHYLOTHORAX; CONFERENCE PAPER; CONSERVATIVE TREATMENT; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; ESOPHAGUS SURGERY; FEASIBILITY STUDY; FEMALE; FISTULA; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; INTUBATION; LOWER ESOPHAGUS SPHINCTER; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; OPERATION DURATION; PERFORATION; PEROPERATIVE COMPLICATION; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SEPSIS; TRACHEA DISEASE; TRACHEOBRONCHIAL TREE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CARDIA; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MORBIDITY; PROSPECTIVE STUDIES; REMISSION INDUCTION; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0043124385     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(03)00274-4     Document Type: Conference Paper

References (25)

1. Kane J.M., Shears L.L., Ribeiro U., Clark M.R., Peterson M., Landreneau R.J., Posner M.C. Is oesophagectomy following upfront chemoradiotherapy safe or necessary? Arch Surg. 132:1997;481-486.
2. Lerut T., De Leyn P., Coosemans W., Van Raemdonck D., Scheys I., Le Saffre E. Surgical strategies in oesophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg. 216:1992;583-590.
3. Apinop C., Puttisak P., Preecha N. A prospective study of combined therapy in oesophageal cancer. Hepatogastroenterology. 41:1994;391-393.
4. Le Prise E., Etienne P., Meunie B., Meddern G., Ben Hassel M., Gedouin D., Campion J.P., Launois B. A randomised study of chemotherapy, radiation therapy, and surgery versus surgery for localised squamous cell carcinoma of the oesophagus. Cancer. 73:1994;1779-1784.
5. Bosset J.F., Gignoux M., Triboulet J.P., Tiret E., Mantion G., Elias D., Lozach P., Ollier J.C., Pavy J.J., Mercier M., Sahmoud T. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of oesophagus. N Engl J Med. 337:1997;161-167.
6. Urba S.G., Orringer M.B., Turrisi A., Iannettoni M., Forastière A., Strawderman M. Randomised trial of preoperative chemoradiation versus surgery alone in patients with locoregional oesophageal carcinoma. J Clin Oncol. 15:2001;305-313.
7. Walsh T.N., Noonan N., Hollywood D., Kelly A., Keeling N., Hennessy T.P. A comparison of multimodal therapy and surgery for oesophageal adenocarcinoma. N Engl J Med. 335:1996;462-467.
8. Lerut T., De Leyn P., Coosemans W., Van Raemdonck D., Cuypers P.H., Van Cleynenbreughel B. Advanced oesophageal carcinoma. World J Surg. 18:1994;379-387.
9. Van Raemdonck D., Van Cutsem E., Menten J., Ectors N., Coosemans W., De Leyn P., Lerut T. Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration. Eur J Cardiothorac Surg. 11:1997;828-837.
10. Keller S.M., Ryan L.M., Coia L.R., Dang P., Vaught D.J., Diggs C., Weiner L.M., Benson A.B. High dose chemoradiotherapy followed by oesophagectomy for adenocarcinoma of the oesophagus and gastroesophageal junction: results of a phase II study of the Eastern Cooperative Oncology Group. Cancer. 83:(9):1998;1908-1916.
11. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 359:2002;1727-1733.
12. Doty J.R., Salazar J.D., Forastiere A., Heath E.I., Kleinberg L., Heitmiller R.F. Postoesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy. Ann Thorac Surg. 74:2002;227-231.
13. Orringer M.B. Substernal gastric bypass of the excluded oesophageal: results of an ill-advised operation. Surgery. 96:1984;467-470.
14. Avendano C.E., Flume P.A., Silvestri G.A., King L.B., Reed C.E. Pulmonary complications after oesophagectomy. Ann Thorac Surg. 73:2002;922-926.
15. Eguchi R., Ide H., Nakamura T., Hayashi K., Ohta M., Okamoto F., Itoh H., Takasaki K. Analysis of postoperative complications after oesophagectomy for oesophageal cancer in patients receiving neoadjuvant therapy. Jpn J Thorac Cardiovasc Surg. 47:(11):1999;552-558.
16. Giri P.G.S., Kimler B.F., Giri U.P., Cox G.G., Reddy E.K. Comparison of single, fractionated and hyperfractionated irradiation on the development of normal tissue damage in rat lung. Int J Radiat Oncol Biol Phys. 11:1985;527-534.
17. Hagry O., Bernard B., Cheynel N., Benoit L., Rat P., Favre J.P. Influence of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality of oesophageal cancer resection. J Chir Thorac Cardio-Vasc. 3:2001;153-157.
18. Van der Maase J., Overgaard J., Vaerth M. Effect of cancer chemotherapeutic drug on radiation-induced lung damage in mice. Radiother Oncol. 5:1986;245-257.
19. Amar D., Burt M.E., Bains M.S., Leung D.H. Symptomatic tachydysrhythmias of oesophagectomy: incidence and outcome measures. Ann Thorac Surg. 61:1996;1506-1509.
20. Swisher S., Holmes E., Hunt K., Doty J., Zinner M., McFadden D. The role of neoadjuvant therapy in surgically respectable oesophageal cancer. Arch Surg. 131:1996;819-825.
21. Hulscher J.B.F., Tijssen J.G.P., Obertop H., Van Lanschot J.J.B. Transthoracic versus transhiatal resection for carcinoma of the oesophagus: a meta-analysis. Ann Thorac Surg. 72:2001;306-313.
22. Lerut T., Coosemans W., De Leyn P., Deneffe G., Topal B., Van de Ven C., Van Raemdonck D. Reflections on three field lymphadenectomy in carcinoma of oesophageal and gastroesophageal junction. Hepatogastroenterology. 46:(26):1999;717-725.
23. Altorki N., Kent M., Ferrara C., Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the oesophagus. Ann Surg. 236:2002;177-183.
24. Tsurumaru M., Kajiyama Y., Udagawa H., Akiyama H. Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic oesophagus. Ann Thoracic Cardiovasc Surg. 7:2001;325-329.
25. Lerut T., Flamen P., Ectors N., Van Cutsem E., Peeters M., Hiele M., De Wever W., Coosemans W., Decker G., De Leyn P., Deneffe G., Van Raemdonck D., Mortelmans L. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the oesophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg. 232:2000;743-752.